113
Views
5
CrossRef citations to date
0
Altmetric
Letter to the Editor

Effect of Filgrastim on Serum Lactate Dehydrogenase and Alkaline Phosphatase Values in Early Breast Cancer Patients

, , , M.D., , , , & show all
Pages 650-653 | Published online: 24 Sep 2004

References

  • Menekay S., Ozsan G. H., Demirkan F., Ozbek D., Ozcan M. A., Fadiloglu M., Undar B. Effect of granulocyte-colony-stimulating factor on serum lactate dehydrogenase levels and isoenzymes in a rabbit model. Acta Haematol. 2002; 107(1)18–22, [PUBMED], [INFOTRIEVE], [CSA]
  • Watanabe T., Suzuya H., Onishi T., Kanai S., Kaneko M., Watanabe H., Nakagawa R., Kawano Y., Takaue Y., Kuroda Y., Talmadge J. E. Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization. Int. J. Hematol. 2003; 77: 75–81, [PUBMED], [INFOTRIEVE], [CSA]
  • Fossa S. D., Poulsen J. P., Aaserud A. Alkaline phospatase and lactate dehydrogenase changes during leucocytosis induced by G-CSF in testicular cancer. The Lancet 1992; 340: 1544, [CROSSREF]
  • Maiche A. G., Muhonen T., Porkka K. Lactate dehydrogenase changes during granulocyte colony-stimulating factor treatment. The Lancet 1992; 340: 853, [CROSSREF]
  • Fukumasu H., Fukumasu Y., Ogita S. Elevation in plasma alkaline phosphatase level during rhG-CSF administration. Granulocytopenic patients with gynecologic cancers treated with cancer chemotherapy. Gynecol. Obstet. Invest. 1998; 45(2)99–104, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
  • Shiraishi K., Sugita K., Inukai T., Iijima K., Tezuka T., Goi K., Kojika S., Nakazawa S. Analysis of serum lactate dehydrogenase and its isozymes during administration of granulocyte colony-stimulating factor in children. Int J Hematol. Aug, 2000; 72(2)194–199, [PUBMED], [INFOTRIEVE], [CSA]
  • Sarris A. H., Majlis A., Dimopoulos M. A., Younes A., Swann F., Rodriguez M. A., McLaughlin P., Cabanillas F. Rising serum lactate dehydrogenase often caused by granulocyte- or granulocyte-macrophage colony stimulating factor and not tumor progression in patients with lymphoma or myeloma. Leuk. Lymphoma May, 1995; 17(5–6)473–477, [PUBMED], [INFOTRIEVE], [CSA]
  • Akizuki S., Mizorogi F., Inoue T., Sudo K., Ohnishi A. Pharmacokinetics and adverse events following 5-day repeated administration of lenograstim, a recombinant human granulocyte colony-stimulating factor, in healthy subjects. Bone Marrow Transplant. Nov, 2000; 26(9)939–946, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.